Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: STCube, Inc.

Market Cap 739B 489M 421M 388M 364M 683M 46.18B 690M 4.58B 1.79B 22.61B 1.83B 1.79B 78.25B P/E Ratio 2024
-19.4x
P/E Ratio 2025 -25.6x
Enterprise Value 682B 451M 388M 357M 335M 630M 42.59B 636M 4.23B 1.65B 20.86B 1.69B 1.66B 72.17B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24-10-23 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
24-08-25 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
24-03-27 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
23-09-06 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
23-03-21 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-03-07 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
20-12-27 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-12-17 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-07-11 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
20-03-02 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
18-05-24 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
18-04-24 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
16-09-19 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day-1.09%
1 week+4.82%
Current month-25.43%
1 month-37.69%
3 months-39.72%
6 months+47.03%
Current year+32.68%
1 week 9,880
Extreme 9880
11,750
1 month 9,460
Extreme 9460
17,290
Current year 6,950
Extreme 6950
22,500
1 year 6,400
Extreme 6400
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 2013-03-28
Director of Finance/CFO 53 -
Chief Tech/Sci/R&D Officer 61 2014-02-28
Director TitleAgeSince
Director/Board Member 61 2013-02-28
Director/Board Member 53 2013-02-28
Director/Board Member 61 2014-02-28
Date Insider Type Main position Quantity % Market Cap.
24-12-02Buy

Chief Executive Officer

18,346 0.0281%
24-12-02
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
24-12-02Buy

Chief Financial Officer

47,582 0.0730%
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%+4.82%+65.60%-32.21% 493M
+4.17%-3.10%+30.48%+7.12% 110B
-0.33%-0.84%+240.61%+457.02% 54.85B
+10.00%+21.15%+494.32%+996.25% 54.3B
+11.47%-4.99%+161.62%+247.01% 41.52B
+4.52%+3.15%+126.77%+93.57% 30.19B
+0.37%+2.61%+28.60%+53.62% 29B
+1.27%-6.28%-13.27%-39.09% 22.57B
+3.08%-13.85%+29.11%+65.42% 19.76B
+0.58%+3.30%-28.60%-30.37% 19.55B
Average +3.41%-2.50%+113.52%+181.83% 38.22B
Weighted average by Cap. +4.49%-2.93%+142.63%+246.98%

Financials

2024 2025
Net sales 11.3B 7.47M 6.44M 5.92M 5.56M 10.44M 706M 10.54M 70.03M 27.36M 346M 28.03M 27.43M 1.2B 6.98B 4.62M 3.98M 3.66M 3.44M 6.45M 436M 6.52M 43.29M 16.91M 214M 17.33M 16.96M 739M
Net income -21.44B -14.17M -12.21M -11.24M -10.55M -19.81M -1.34B -20.01M -133M -51.91M -656M -53.18M -52.05M -2.27B -21.8B -14.41M -12.42M -11.43M -10.72M -20.14M -1.36B -20.34M -135M -52.79M -667M -54.08M -52.93M -2.31B
Net Debt -79.55B -52.59M -45.32M -41.71M -39.13M -73.51M -4.97B -74.24M -493M -193M -2.43B -197M -193M -8.42B -57.42B -37.96M -32.71M -30.11M -28.25M -53.06M -3.59B -53.59M -356M -139M -1.76B -142M -139M -6.08B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
26-06-14 10,880.00 -1.09% 242,825
26-06-12 11,000.00 -2.31% 291,068
26-06-11 11,260.00 +5.63% 310,298
26-06-10 10,660.00 +1.52% 524,135
26-06-09 10,500.00 +7.47% 433,537
  1. Stock Market
  2. Stocks
  3. A052020 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!